8-K - Tango Therapeutics, Inc. (0001819133) (Filer)
Published . Updated .
Key takeaways
- 8-K - Tango Therapeutics filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
- Exposed: TNGX
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Tango Therapeutics filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
Directly affected
- TNGX Tango Therapeutics-23.1% 12d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Tango Therapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and+14.3% 30d
Eli Lilly and is a peer of Tango Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+3.3% 30d
Johnson & Johnson is a peer of Tango Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+9.3% 30d
AbbVie is a peer of Tango Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.4% 30d
Merck is a peer of Tango Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+6.8% 30d
Abbott Laboratories is a peer of Tango Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| TNGX | +1.19% | +7.82% | base | after close | after close | after close | after close |
| XLV | -0.10% | +2.63% | base | after close | after close | after close | after close |
| LLY | +4.21% | +4.67% | base | after close | after close | after close | after close |
| JNJ | -2.08% | +0.00% | base | after close | after close | after close | after close |
| ABBV | -0.93% | +1.16% | base | after close | after close | after close | after close |
| MRK | +1.15% | +2.46% | base | after close | after close | after close | after close |
| ABT | +0.28% | +5.08% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-09 AccNo: 0001193125-26-452635 Size: 414 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Tango Therapeutics (TNGX) has moved since 9 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | +1.16% | final price |
| ABBV | five days earlier | -0.93% | final price |
| ABT | three days earlier | +5.08% | final price |
| ABT | five days earlier | +0.28% | final price |
| JNJ | three days earlier | 0.00% | final price |
| JNJ | five days earlier | -2.08% | final price |
| LLY | three days earlier | +4.67% | final price |
| LLY | five days earlier | +4.21% | final price |
| MRK | three days earlier | +2.46% | final price |
| MRK | five days earlier | +1.15% | final price |
| Tango Therapeutics (TNGX) | three days earlier | +7.82% | final price |
| Tango Therapeutics (TNGX) | five days earlier | +1.19% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 40 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 45 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 62 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 56 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 82 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 38 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 52 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Abbott Laboratories (ABT), worth $1,001 - $15,000 on 17 Sep 2026. That is 53 days before publication. Filed 30 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Tango Therapeutics (TNGX)
Companies carried with this story
- TNGX Tango Therapeutics
Tango Therapeutics (TNGX) is linked, with no stored direction, high confidence in the 9 Nov 2026 story “8-K - Tango Therapeutics, Inc. (0001819133) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> TNGX
How “8-K - Tango Therapeutics, Inc. (0001819133) (Filer)” reaches Tango Therapeutics (TNGX)
“8-K - Tango Therapeutics, Inc. (0001819133) (Filer)” (9 Nov 2026) reaches Tango Therapeutics (TNGX) through this story.
Tango Therapeutics (TNGX) is on the page because SEC 8-K filing -> direct issuer disclosure -> TNGX
Price levels for Tango Therapeutics (TNGX)
TNGX traded between 20.79 and 27.98 across 12 sessions. The latest close on file is 21.48.
What the saved facts support for Tango Therapeutics (TNGX)
14 out of 100
“8-K - Tango Therapeutics, Inc. (0001819133) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.